LIGAND PHARMACEUTICALS INCORPORATED Other Significant Noncash Transaction, Value of Consideration Received
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Other Significant Noncash Transaction, Value of Consideration Received of $3.90 million as of 2018-05-23, per its 10-K filed 2019-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherSignificantNoncashTransactionValueOfConsiderationReceived1 · last filed 2019-02-28
- 2018-05-23: Other Significant Noncash Transaction, Value of Consideration Received $3.90M.
| Period end | Other Significant Noncash Transaction, Value of Consideration Received |
|---|---|
| 2018-05-23 | $3.90M 10-K · filed 2019-02-28 |